MI Bioresearch

About:

MI Bioresearch is a contract research organization providing in vivo preclinical imaging services.

Website: http://www.molecularimaging.com

Twitter/X: mibioresearch

Top Investors: Invest Detroit, Beringea, Baird Capital, InvestMichigan, Arcus Ventures

Description:

MI Bioresearch is a specialty contract research organization (CRO) providing in vivo preclinical imaging services. With a proven track record of imaging and drug discovery expertise, the company enhances preclinical and translational research through its in vivo pharmaco-IMAGING platform. This combination of traditional pharmacology and innovative imaging includes MRI, micro-CT, micro-PET, SPECT and optical (bioluminescence and fluorescence molecular tomography) tools to quantitatively measure the response to therapy at anatomical, functional and molecular levels. Molecular Imaging also provides supportive in vitro services. They have performed over 2000 cell line based traditional oncology studies and over 500 imaging enhanced studies since their founding in 2003.

Total Funding Amount:

$22M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ann Arbor, Michigan, United States

Founded Date:

2003-01-01

Contact Email:

frank(AT)molecularimaging.com

Founders:

Patrick McConville, Wilbur R. Leopold III

Number of Employees:

11-50

Last Funding Date:

2014-12-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai